Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: a novel mechanism of glucagon-stimulated lipolysis? (Q28571194)

From Wikidata

Jump to navigation Jump to search

scientific journal article

Language	Label	Description	Also known as
English	Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: a novel mechanism of glucagon-stimulated lipolysis?	scientific journal article

Statements

scholarly article

1 reference

31 January 2017

Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: a novel mechanism of glucagon-stimulated lipolysis? (English)

1 reference

31 January 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Marek Skrzypski

object named as

M. Skrzypski

3

0 references

Tatiana Wojciechowicz

object named as

T. Wojciechowicz

8

0 references

object named as

M. Sassek

7

0 references

author name string

A. M. Arafat

1

1 reference

31 January 2017

P. Kaczmarek

2

1 reference

31 January 2017

E. Pruszyńska-Oszmalek

4

1 reference

31 January 2017

P. Kołodziejski

5

1 reference

31 January 2017

D. Szczepankiewicz

6

1 reference

31 January 2017

B. Wiedenmann

9

1 reference

31 January 2017

A. F. H. Pfeiffer

10

1 reference

31 January 2017

K. W. Nowak

11

1 reference

31 January 2017

M. Z. Strowski

12

1 reference

31 January 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 March 2013

1 reference

31 January 2017

1 reference

31 January 2017

56

1 reference

31 January 2017

3

1 reference

31 January 2017

588–597

1 reference

31 January 2017

https://scigraph.springernature.com/pub.10.1007/s00125-012-2803-y

0 references

FGF-21 as a novel metabolic regulator

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2803-Y

21 January 2018

Identification of a novel FGF, FGF-21, preferentially expressed in the liver

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2803-Y

21 January 2018

Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2803-Y

21 January 2018

FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2803-Y

21 January 2018

Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2803-Y

21 January 2018

FGF21 attenuates lipolysis in human adipocytes - a possible link to improved insulin sensitivity

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2803-Y

21 January 2018

Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2803-Y

21 January 2018

Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2803-Y

21 January 2018

Effects of nutritional state, insulin, and glucagon on lipid mobilization in rainbow trout, Oncorhynchus mykiss

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2803-Y

21 January 2018

Hypocaloric high-protein diet improves fatty liver and hypertriglyceridemia in sucrose-fed obese rats via two pathways

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2803-Y

21 January 2018

Paradoxical regulation of human FGF21 by both fasting and feeding signals: is FGF21 a nutritional adaptation factor?

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2803-Y

21 January 2018

Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2803-Y

21 January 2018

Glucagon and lipid interactions in the regulation of hepatic AMPK signaling and expression of PPARalpha and FGF21 transcripts in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2803-Y

21 January 2018

The glucagon receptor is required for the adaptive metabolic response to fasting

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2803-Y

21 January 2018

Free fatty acids link metabolism and regulation of the insulin-sensitizing fibroblast growth factor-21.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2803-Y

21 January 2018

Physiological modulation of circulating FGF21: relevance of free fatty acids and insulin.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2803-Y

21 January 2018

Glucagon inhibits ghrelin secretion in humans.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2803-Y

21 January 2018

Glucagon suppression of ghrelin secretion is exerted at hypothalamus-pituitary level.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2803-Y

21 January 2018

Streptozotocin-induced diabetes in the rat is associated with changes in vaginal hemodynamics, morphology and biochemical markers

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2803-Y

21 January 2018

Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta -hydroxysteroid dehydrogenase type 1 expression and activity

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2803-Y

21 January 2018

Chapter 4 Preparation of Isolated Rat Liver Cells

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2803-Y

21 January 2018

Orexin A stimulates glucose uptake, lipid accumulation and adiponectin secretion from 3T3-L1 adipocytes and isolated primary rat adipocytes.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2803-Y

21 January 2018

Fibroblast growth factor-21 is induced in human skeletal muscles by hyperinsulinemia

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2803-Y

21 January 2018

Histologic distribution of insulin and glucagon receptors.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2803-Y

21 January 2018

Relative quantitative analysis of glucagon receptor mRNA in rat tissues

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2803-Y

21 January 2018

Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2803-Y

21 January 2018

Growth hormone induces hepatic production of fibroblast growth factor 21 through a mechanism dependent on lipolysis in adipocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2803-Y

21 January 2018

Elevated serum growth hormone in a patient with Type 1 diabetes: a diagnostic dilemma

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2803-Y

21 January 2018

Potentiation of glucose uptake in 3T3-L1 adipocytes by PPAR gamma agonists is maintained in cells expressing a PPAR gamma dominant-negative mutant: evidence for selectivity in the downstream responses to PPAR gamma activation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23262585

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Physiological effect of glucagon in human isolated adipocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/23262585

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of insulin on glucagon enhanced lipolysis in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/23262585

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of the glucagon receptor and its functional domains using monoclonal antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/23262585

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of a selective endothelin a receptor antagonist on the expressions of iNOS and eNOS in the heart of early streptozotocin-induced diabetic rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/23262585

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

METABOLISM OF ISOLATED FAT CELLS. I. EFFECTS OF HORMONES ON GLUCOSE METABOLISM AND LIPOLYSIS

1 reference

https://pubmed.ncbi.nlm.nih.gov/23262585

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00125-012-2803-Y

1 reference

31 January 2017

Dimensions Publication ID

0 references

1 reference

31 January 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28571194&oldid=1982685706"